Oral Bisoprolol for the treatment of non-resolving central serous chorioretinopathy: A case report
Open Access
- 12 June 2020
- journal article
- Published by Peertechz Publications Private Limited in Journal of Clinical Research and Ophthalmology
- Vol. 7 (1), 033-036
- https://doi.org/10.17352/2455-1414.000070
Abstract
Idiopathic macular telangiectasia type 2 (MacTel) is known with temporal juxtafoveal retinal capillaries dilation and telangiectasia.Keywords
This publication has 18 references indexed in Scilit:
- Treatment of central serous chorioretinopathy with beta-blocker metipranololBiomedical Papers, 2015
- Central Serous Chorioretinopathy: Update on Pathophysiology and TreatmentSurvey of Ophthalmology, 2013
- Half-Dose Verteporfin Photodynamic Therapy for Acute Central Serous Chorioretinopathy: One-Year Results of a Randomized Controlled TrialOphthalmology, 2008
- Central serous chorioretinopathyActa Ophthalmologica, 2008
- The Use of Propranolol to Treat Central Serous Chorioretinopathy: An Evaluation by Serial OCTJournal of Ocular Pharmacology and Therapeutics, 2006
- Long‐term macular function in eyes with central serous chorioretinopathyClinical & Experimental Ophthalmology, 2005
- Central Serous Chorioretinopathy and GlucocorticoidsSurvey of Ophthalmology, 2002
- Acetazolamide for central serous retinopathyOphthalmology, 2002
- Die Behandlung der zentralen serösen Choroidopathie mit dem Betarezeptorenblocker Metoprolol (Vorläufige Ergebnisse)Klinische Monatsblätter für Augenheilkunde, 1993
- TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHYRetina, 1987